Gf Fund Management Co. Ltd. Vertex Pharmaceuticals Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 60,812 shares of VRTX stock, worth $27.1 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
60,812
Previous 59,178
2.76%
Holding current value
$27.1 Million
Previous $23.8 Billion
23.72%
% of portfolio
0.69%
Previous 0.52%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,829Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.51 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.48 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.26 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $114B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...